1. Home
  2. CORT vs KVYO Comparison

CORT vs KVYO Comparison

Compare CORT & KVYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CORT
  • KVYO
  • Stock Information
  • Founded
  • CORT 1998
  • KVYO 2012
  • Country
  • CORT United States
  • KVYO United States
  • Employees
  • CORT N/A
  • KVYO N/A
  • Industry
  • CORT Biotechnology: Pharmaceutical Preparations
  • KVYO
  • Sector
  • CORT Health Care
  • KVYO
  • Exchange
  • CORT Nasdaq
  • KVYO Nasdaq
  • Market Cap
  • CORT 7.6B
  • KVYO 8.3B
  • IPO Year
  • CORT N/A
  • KVYO 2023
  • Fundamental
  • Price
  • CORT $80.94
  • KVYO $28.38
  • Analyst Decision
  • CORT Strong Buy
  • KVYO Strong Buy
  • Analyst Count
  • CORT 5
  • KVYO 24
  • Target Price
  • CORT $139.00
  • KVYO $43.17
  • AVG Volume (30 Days)
  • CORT 639.6K
  • KVYO 3.4M
  • Earning Date
  • CORT 11-04-2025
  • KVYO 11-05-2025
  • Dividend Yield
  • CORT N/A
  • KVYO N/A
  • EPS Growth
  • CORT N/A
  • KVYO N/A
  • EPS
  • CORT 0.87
  • KVYO N/A
  • Revenue
  • CORT $741,172,000.00
  • KVYO $1,153,988,000.00
  • Revenue This Year
  • CORT $28.85
  • KVYO $30.67
  • Revenue Next Year
  • CORT $34.98
  • KVYO $21.55
  • P/E Ratio
  • CORT $91.92
  • KVYO N/A
  • Revenue Growth
  • CORT 17.92
  • KVYO 32.81
  • 52 Week Low
  • CORT $49.00
  • KVYO $23.44
  • 52 Week High
  • CORT $117.33
  • KVYO $49.55
  • Technical
  • Relative Strength Index (RSI)
  • CORT 61.15
  • KVYO 54.38
  • Support Level
  • CORT $73.79
  • KVYO $26.21
  • Resistance Level
  • CORT $78.99
  • KVYO $28.43
  • Average True Range (ATR)
  • CORT 3.03
  • KVYO 1.48
  • MACD
  • CORT 0.61
  • KVYO 0.02
  • Stochastic Oscillator
  • CORT 95.41
  • KVYO 53.92

About CORT Corcept Therapeutics Incorporated

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.

About KVYO Klaviyo Inc. Series A

Klaviyo Inc is a technology company that provides a software-as-a-service (SaaS) platform to enable its customers to send the right messages at the right time across email, short message service, and push notifications, more accurately measure and predict performance, and deploy specific actions and campaigns. The platform combines proprietary data and application layers into one solution with machine learning and artificial intelligence capabilities. It is focused on marketing automation within eCommerce as its first application use case. It generates revenue through the sale of subscriptions to its customers for the use of its platform. Geographically, the company generates the majority of its revenue from the Americas, followed by EMEA and APAC.

Share on Social Networks: